Some biomarkers such as carcinoembryonic antigen (CEA), and neuron-specific enolase (NSE) were used to diagnose lung cancer while the diagnostic abilities of these serum markers are limited in sensitivity and specificity (10–13). This evidence concerns the gene ENO2 and lung cancer.